Society Pass (SoPa) Reports Full Year 2021 Financial Results, Sees 891% Year on Year Revenue Growth
SINGAPORE, Mar 24, 2022 – (ACN Newswire) – Society Pass Incorporated (SoPa) (Nasdaq: “SOPA”), a…
SINGAPORE, Mar 24, 2022 – (ACN Newswire) – Society Pass Incorporated (SoPa) (Nasdaq: “SOPA”), a…
TOKYO, Mar 24, 2022 – (ACN Newswire) – TANAKA Kikinzoku Kogyo K.K. (Head office: Chiyoda-ku,…
HONG KONG, Mar 24, 2022 – (ACN Newswire) – Vertical International Holdings Limited, stock code…
Singapore, Mar 24, 2022 – (ACN Newswire) – Alpina Holdings Limited (the “Company”, and together…
Regulated information — Inside information Read moreUltimate Guide: Everything You Need to Know…
NEW YORK, March 23, 2022 (GLOBE NEWSWIRE) — Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in…
SAN JOSE, Calif., March 23, 2022 (GLOBE NEWSWIRE) — Rani Therapeutics Holdings, Inc. (“Rani Therapeutics”…
London, United Kingdom–(Newsfile Corp. – March 23, 2022) – The SpaceMeta token project is the…
HONG KONG, Mar 24, 2022 – (ACN Newswire) – VCREDIT Holdings Limited (“VCREDIT” or the…
NEW YORK / PERTH, Mar 24, 2022 – (ACN Newswire) – Yowie Group, the confectionary…
The New Facility is the Company’s First in North America TUCSON, Ariz.–(BUSINESS WIRE)–nVent Electric plc…
Rollout of 140 service robots represents industry’s single biggest contract for humanoid robots to provide…
RICHMOND, Va.–(BUSINESS WIRE)–$GNW #genworth–Genworth Financial, Inc. (NYSE: GNW) today announced the election of a new…
LEIDEN, Netherlands & CAMBRIDGE, Mass., March 23, 2022 (GLOBE NEWSWIRE) — ProQR Therapeutics N.V. (Nasdaq:…
— Conference call to be held March 30, 2022, at 4:30 p.m. ET — BRIDGEWATER,…
PHILADELPHIA, March 23, 2022 (GLOBE NEWSWIRE) — Century Therapeutics (NASDAQ: IPSC), an innovative biotechnology company…
Ad hoc announcement pursuant to Art. 53 LR FDA also approved complementary diagnostic imaging agent,…
BOSTON and LONDON, March 23, 2022 (GLOBE NEWSWIRE) — Centessa Pharmaceuticals plc (Nasdaq: CNTA) announced…
SOUTH SAN FRANCISCO, Calif., March 23, 2022 (GLOBE NEWSWIRE) — CytomX Therapeutics, Inc. (Nasdaq: CTMX),…
Commenced enrollment in Phase 1 trial with orally administered, broad-spectrum antiviral agent CC-42344 for the…